You have 9 free searches left this month | for more free features.

fingolimod

Showing 1 - 25 of 45

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Stroke Inflammation Trial in Fuzhou (Fingolimod)

Recruiting
  • Stroke Inflammation
  • Fingolimod
  • Fuzhou, China
    The First Affiliated Hospital of Fujian Medical University
Apr 12, 2022

Chemo-Induced Peripheral Neuropathy, Numbness, Pain Trial in Rochester, Columbus (Fingolimod, Fingolimod Hydrochloride,

Active, not recruiting
  • Chemotherapy-Induced Peripheral Neuropathy
  • +3 more
  • Fingolimod
  • +2 more
  • Rochester, Minnesota
  • +1 more
Dec 7, 2021

Impact of Fingolimod Adherence on Outcomes

Completed
  • Multiple Sclerosis
  • Fingolimod
  • East Hanover, New Jersey
    Novartis Investigational Site
Dec 15, 2021

Diabetes, Type 2 Trial in Shenyang (Fingolimod, guideline-based treatment for DM)

Recruiting
  • Diabetes Mellitus, Type 2
  • Fingolimod
  • guideline-based treatment for DM
  • Shenyang, China
    Department of Neurology, General Hospital of Northern Theater Co
Mar 31, 2022

Generic Fingolimod in Relapsing-Remitting Multiple Sclerosis in

Recruiting
  • Relapsing-Remitting Multiple Sclerosis
  • Fingolimod
  • Alexandria, Egypt
  • +1 more
Jun 14, 2022

Stroke, Inflammation Trial in Hangzhou (Fingolimod)

Withdrawn
  • Stroke
  • Inflammation
  • Fingolimod
  • Hangzhou, Zhejiang, China
    The second affiliated hospital of Zhejiang University
Jul 15, 2021

Stroke Trial (Fingolimod, )

Not yet recruiting
  • Stroke
  • Fingolimod
  • placebo
  • (no location specified)
Jan 17, 2021

Interstitial Fibrosis, Kidney Transplant; Complications, Kidney Transplant Rejection Trial in Houston (Fingolimod, Placebo)

Not yet recruiting
  • Interstitial Fibrosis
  • +6 more
  • Fingolimod
  • Placebo
  • Houston, Texas
    Houston Methodist Research Institute
Mar 8, 2022

Multiple Sclerosis Trial in Belgium, Germany, Italy (Fingolimod)

Completed
  • Multiple Sclerosis
  • Fingolimod
  • Gent, Belgium
  • +3 more
Jan 21, 2021

Multiple Sclerosis (MS) Trial in Worldwide (Fingolimod, Ofatumumab, Siponimod)

Recruiting
  • Multiple Sclerosis (MS)
  • Fingolimod
  • +5 more
  • Little Rock, Arkansas
  • +44 more
Aug 24, 2022

Relapsing-Remitting Multiple Sclerosis Trial in Worldwide (Ocrelizumab, Ocrelizumab Placebo, Fingolimod)

Recruiting
  • Relapsing-Remitting Multiple Sclerosis
  • Aurora, Colorado
  • +31 more
Jul 26, 2022

Relationship Between Oral DMT Burden and Adherence in MS

Enrolling by invitation
  • Multiple Sclerosis
  • Adherence, Medication
  • Melbourne, Victoria, Australia
    Monash University
Dec 16, 2020

Relapsing Remitting Multiple Sclerosis Trial in Milan (Fingolimod, Dimethyl Fumarate)

Terminated
  • Relapsing Remitting Multiple Sclerosis
  • Fingolimod
  • Dimethyl Fumarate
  • Milan, Italy
    Fondazione IRCCS Istituto Neurologico C. Besta, Neuroimmunology
Oct 29, 2019

Relapsing Multiple Sclerosis Trial in United States (Fingolimod)

Completed
  • Relapsing Multiple Sclerosis
  • Fingolimod
  • Birmingham, Alabama
  • +65 more
Oct 6, 2021

Multiple Sclerosis Trial (Fingolimod, Fish Oil, Placebo (for Fish Oil))

Completed
  • Multiple Sclerosis
  • Fingolimod
  • +2 more
  • (no location specified)
Apr 23, 2019

Schizophrenia Trial in Indianapolis (Fingolimod, )

Completed
  • Schizophrenia
  • Fingolimod
  • placebo
  • Indianapolis, Indiana
  • +2 more
Mar 25, 2019

Relapsing Remitting Multiple Sclerosis RRMS Trial in Germany, Switzerland (Fingolimod)

Completed
  • Relapsing Remitting Multiple Sclerosis RRMS
  • Fingolimod
  • Bochum, Germany
  • +9 more
Feb 14, 2020

Relapsing Remitting Multiple Sclerosis Trial in Puerto Rico, United States (Fingolimod, Disease Modifying therapy)

Completed
  • Relapsing Remitting Multiple Sclerosis
  • Fingolimod
  • Disease Modifying therapy
  • Cullman, Alabama
  • +122 more
Dec 9, 2020

Relapsing-remitting Multiple Sclerosis Trial in Germany (fingolimod)

Completed
  • Relapsing-remitting Multiple Sclerosis
  • fingolimod
  • Ostfildern, Baden-Wuerttemberg, Germany
  • +25 more
Sep 6, 2018

Multiple Sclerosis Treated Fingolimod or Other Approved

Completed
  • Multiple Sclerosis
  • other disease-modifying therapy
  • Fingolimod
  • Birmingham, Alabama
  • +237 more
Dec 28, 2021

Relapsing Forms of Multiple Sclerosis Trial in Worldwide (Fingolimod)

Completed
  • Relapsing Forms of Multiple Sclerosis
  • Fingolimod
  • Cullman, Alabama
  • +457 more
Mar 26, 2021

Stroke, Vascular Accident, Cerebral Stroke Trial in Tianjin (Fingolimod)

Completed
  • Stroke
  • +4 more
  • Fingolimod
  • Tianjin, Tianjin, China
    Tianjin Medical University General Hospital
Oct 15, 2018

Relapsing-remitting Multiple Sclerosis (RRMS) Trial in Worldwide (fingolimod, glatiramer acetate)

Terminated
  • Relapsing-remitting Multiple Sclerosis (RRMS)
  • fingolimod
  • glatiramer acetate
  • Cullman, Alabama
  • +129 more
Apr 29, 2019

Glioblastoma, Anaplastic Astrocytoma Trial in Baltimore (Fingolimod)

Completed
  • Glioblastoma
  • Anaplastic Astrocytoma
  • Fingolimod
  • Baltimore, Maryland
    The Johns Hopkins University
Sep 12, 2017

Multiple Sclerosis (Relapsing Remitting) Trial (fingolimod, Placebo (6mos) + open label fingolimod (6 mos))

Withdrawn
  • Multiple Sclerosis (Relapsing Remitting)
  • fingolimod
  • Placebo (6mos) + open label fingolimod (6 mos)
  • (no location specified)
Apr 20, 2017